All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAART-LX071 | Anti-Glycoprotein Iib/IIIa (X8LX149) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | X8LX149 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX072 | Anti-Glycoprotein Iib/IIIa (PAC-1) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | PAC-1 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX073 | Anti-Glycoprotein Iib/IIIa (X8LX147) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | X8LX147 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX074 | Anti-Glycoprotein Iib/IIIa (X8LX148) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | X8LX148 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX075 | Anti-Glycoprotein Iib/IIIa (X8LX150) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | X8LX150 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX076 | Anti-Glycoprotein Iib/IIIa (X8LX146) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | X8LX146 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX077 | Anti-Glycoprotein Iib/IIIa (34D10) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | 34D10 | Humanized | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX078 | Anti-Glycoprotein Iib/IIIa (X8LX149) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | X8LX149 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX079 | Anti-Glycoprotein Iib/IIIa (PAC-1) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | PAC-1 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX080 | Anti-Glycoprotein Iib/IIIa (X8LX147) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | X8LX147 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX081 | Anti-Glycoprotein Iib/IIIa (X8LX148) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | X8LX148 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX082 | Anti-Glycoprotein Iib/IIIa (X8LX150) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | X8LX150 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX083 | Anti-Glycoprotein Iib/IIIa (X8LX146) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | X8LX146 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX084 | Anti-Glycoprotein Iib/IIIa (34D10) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | 34D10 | Humanized | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION